-
My Account
In App
My Account
BSE Live
Jan 16, 16:01Prev. Close
6356.75
Open Price
6317.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 16, 15:54Prev. Close
6355.50
Open Price
6355.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Divis Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 388.34 | 458.34 | 384.69 | 226.70 | 106.91 | |
| Net CashFlow From Operating Activities | 367.67 | 315.51 | 302.11 | 189.68 | 49.89 | |
| Net Cash Used In Investing Activities | -317.18 | -232.11 | -235.48 | -158.87 | -112.29 | |
| Net Cash Used From Financing Activities | -47.60 | -82.31 | -65.08 | -34.00 | 68.07 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2.89 | 1.09 | 1.55 | -3.19 | 5.68 | |
| Cash And Cash Equivalents Begin of Year | 6.90 | 5.81 | 4.27 | 7.46 | 1.79 | |
| Cash And Cash Equivalents End Of Year | 9.80 | 6.90 | 5.81 | 4.27 | 7.46 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill
